Question Bank › Event-dense runway

Event-dense runway

Event-dense runway: management frames the coming quarters as a calendar of its own named, scheduled events

Calls Tested
422
Answered YES
22
Hit Rate
5.2%
rare by design

Kite Realty Group Trust (KRG) — this company's answers

NO on the Q1 2018 call 2018-04-26 C+
The model's full reasoning — Q1 2018 call → NO我们根据指令,只使用提供的电话会议记录。问题:管理层是否将公司近期(未来几个季度)描述为一系列具体的、已命名的、已安排的公司自身事件的日历,并将完成这一事件序列作为公司未来走向的核心叙事? 分析电话会议内容: - 管理层讨论了出售资产(Memorial Commons和Trussville Promenade),但这是过去的事件。 - 关于未来,他们提到“Big Box Surge initiative”取得了进展,执行了两份租赁(Gander Outdoors和Party City),并提到有五个已执行的意向书,正在谈判。这些是具体的租赁事件,但时间上未明确锚定(“currently”)。 - 他们提到“3-R activity”,成功过渡了Burnt Store Marketplace,有六个在建项目,预计在年内稳定。这些是具体的项目,有大致时间(“throughout the remainder of the year”)。 - 提到Fishers Station,Kroger Marketplace不开了,但有一个20年的地面租约,租金从9月开始支付。这是一个具体事件。 - 提到重新谈判了信贷额度,但那是财务操作。 - 关于未来,他们重申了2018年指引,但没有详细的事件日历。 关键点:管理层是否将未来几个季度组织为多个具体的、已安排的公司事件?他们提到了几个租赁交易、3-R项目、以及一个租约开始。但这些事件是否被呈现为“日历”并作为核心叙事?他们更多是在讨论运营进展和租赁活动,而不是一个明确的事件序列。他们提到“我们继续探索出售资产”,但那是探索性的。他们提到“Big Box Surge”有进展,但未给出具体时间表。3-R项目有“预计在年内稳定”,但那是多个项目。Fishers Station的租约开始是具体事件。 然而,这些事件是否构成“多个不同的、具体的、已安排的公司事件”?是的,有租赁执行、项目稳定、租约开始。但管理层是否将这些作为“公司未来走向的核心叙事”?他们更多是在回顾第一季度业绩,并提到一些未来活动,但并没有一个清晰的“事件日历”作为主要框架。他们讨论的重点是当前业绩、租赁利差、同店NOI、资产负债表等。未来事件是分散提及的,而不是一个统一的日历。 此外,他们提到“我们目前有五个已执行的意向书”,但那是意向书,不是已确定的租赁。他们提到“我们正在谈判”,但那是进行中。 指令要求:如果未来讨论主要是关于市场条件、需求、宏观因素、定价或成本控制,而没有公司特定事件的日历,则回答NO。这里,管理层确实讨论了市场条件(如零售环境、买家需求),但也有一些具体事件。然而,这些事件是否被呈现为“已安排”的?他们提到“预计在年内稳定”,那是时间范围,但不够具体。他们提到“租金从9月开始”,那是具体时间。 但整体上,管理层并没有将未来几个季度组织为一个事件序列。他们更多是在总结当前状态和展望,而不是列出即将发生的事件。他们提到“我们继续探索出售资产”,那是探索性的。他们提到“我们正在谈判”,那是进行中。 因此,我认为答案应为NO,因为未来讨论主要是关于当前业绩和市场条件,而不是一个明确的公司事件日历。尽管有一些具体事件,但不足以构成“多个不同的、已安排的事件”作为核心叙事。 所以回答NO。

← Back to the full KRG analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management frame the company's NEAR FUTURE — roughly the next few quarters — as a CALENDAR OF ITS OWN SPECIFIC, NAMED, ALREADY-SCHEDULED EVENTS, and treat working through that event sequence as the central story of where the company is heading? Answer YES when management's own words convey, in whatever form fits the business, ONE coherent posture: the forward-looking discussion is organized around MULTIPLE distinct, concrete happenings that belong to the company itself and are expected to occur soon — each one identifiable and time-anchored in management's telling (this quarter, next quarter, by mid-year, this season, in the coming months). The events may take whatever form fits the industry — for example: a facility, line, site, store format, or capacity starting up or opening; a product, program, service, or offering launching or shipping; a ramp, rollout, or expansion beginning or reaching its next stage; a first delivery, first production, first cohort, or go-live; a submission, decision, certification, data readout, or approval date; a contract, program, or partnership commencing; a new market or channel switching on. What matters is that (a) there are SEVERAL such distinct company-specific events, not just one; (b) management anchors them in the near term with at least rough timing, presenting them as scheduled or in motion rather than aspirational; and (c) management treats this sequence of upcoming events — rather than general market conditions, demand trends, or cost management — as the main engine of the company's next stage, with the call's forward energy devoted to what is about to happen and how the company is preparing for each step. Answer NO if the forward discussion is chiefly about market conditions, demand strength or weakness, macro factors, pricing, or cost control, with no calendar of company-specific events. NO if there is only ONE meaningful upcoming event, however large. NO if the future items are vague ambitions, pipeline hopes, exploratory initiatives, or opportunities without stated near-term timing. NO if the named events are routine recurring housekeeping this business always has (ordinary seasonal openings at the usual pace, standard annual product refreshes, scheduled maintenance) that management does not present as changing the company's trajectory. NO if management mentions upcoming milestones only in passing while the call's substance is defending current results. NO if the events are mainly things happening TO the company from outside (market recoveries, customer budget cycles, industry conditions) rather than the company's own scheduled actions. NO if the event calendar appears only in an analyst's question or summary that management does not itself adopt. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
RCEL AVITA Medical, Inc. Q1 2024 2024-05-14 F
ERO Ero Copper Corp. Q1 2024 2024-05-10 A
LILA Liberty Latin America Ltd. Q4 2023 2024-02-23 C
BRBR BellRing Brands, Inc. Q4 2023 2023-11-21 B+
SBS Companhia de Saneamento Básico do Estado Q3 2023 2023-11-10 C+
PTN Palatin Technologies, Inc. Q4 2023 2023-09-29 D
NBTX Nanobiotix S.A. Q2 2023 2023-09-27 D
PTLO Portillo's Inc. Q2 2023 2023-08-05 B
BEAT BioTelemetry's Q4 2022 2023-03-17 D
ARWR Arrowhead Pharmaceuticals, Inc. Q4 2022 2022-11-28 D
FLL Full House Resorts, Inc. Q3 2022 2022-11-07 B
ASTS AST SpaceMobile, Inc. Q2 2022 2022-08-15 D
HROW Harrow Health, Inc. Q4 2021 2022-03-10 C
EEX Emerald Holding, Inc. Q2 2021 2021-08-01 C+
AGIO Agios Pharmaceuticals, Inc. Q3 2018 2018-11-01 C
ALKS Alkermes plc Q3 2018 2018-10-23 C
AU AngloGold Ashanti's Q2 2018 2018-08-20 B
ITCI Intra-Cellular Therapies, Inc. Q4 2017 2018-03-01 D
PCRX Pacira BioSciences, Inc. Q4 2017 2018-02-28 C
IONS Ionis Pharmaceuticals, Inc. Q1 2017 2017-05-09 C
FATE Fate Therapeutics, Inc. Q3 2016 2016-11-07 C
DUK Duke Energy Corporation Q2 2016 2016-08-04 B

How the model reasoned

PCRX · Q4 2017 → YESThe question is: Does management frame the company's NEAR FUTURE — roughly the next few quarters — as a CALENDAR OF ITS OWN SPECIFIC, NAMED, ALREADY-SCHEDULED EVENTS, and treat working through that ev...YES Management frames the near-term outlook (2018) as a concrete calendar of its own named, time-anchored events—nerve-block label expansion, C-section study readout, additional Phase 4 study launches, CMS reimbursement decisions, and new partnerships—treating the execution of this sequence as the primary driver of 2018 growth and strategic progress. These are presented as scheduled company actions rather than general market trends, with explicit timing (e.g., mid-year FDA meetings, second-half manufacturing ramp, AAOS programs) and positioned as the central story of where the company is heading.
AU · Q2 2018 → YESThe question is: Does management frame the company's NEAR FUTURE — roughly the next few quarters — as a CALENDAR OF ITS OWN SPECIFIC, NAMED, ALREADY-SCHEDULED EVENTS, and treat working through that ev...YES Management structures the forward outlook around a clear sequence of its own named, time-anchored events—Kibali underground ramp-up and Azambi hydropower station (Q3), Siguiri CIL circuit and power plants (Q4), Obuasi redevelopment milestones (first gold end-2019), Mponeng 6-month backfill plant start (H2), South Africa Section 189 process and wage negotiations (Q3), plus production upticks at multiple sites—presenting these as the primary drivers of the next stage rather than generic market or cost themes.
HROW · Q4 2021 → YESThe question is: Does management frame the company's NEAR FUTURE — roughly the next few quarters — as a CALENDAR OF ITS OWN SPECIFIC, NAMED, ALREADY-SCHEDULED EVENTS, and treat working through that ev...YES The transcript shows management organizing the near-term outlook around a clear sequence of its own named, time-anchored events: AMP-100 PDUFA on October 16 (with launch a few months later), Surface Opthalmics data readout in a few months, Melt Pharmaceuticals top-line data soon after, and internal product 18-month launches, plus MAQ-100 FDA meeting mid-year and relaunch preparations for IOPIDINE/MAXITROL/MOXEZA.

More from the question bank

Second engine igniting off the firstManagement is buying/committing capital at aThe leak is fixed: the company is keeping whDemand pull is outrunning the plan for one sBet-the-company financing already spent on hSaid-then-did: management reports back on itAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.